Cancer Institute of New Jersey at Cooper University Hospital - Camden
Camden, New Jersey 08103
0 studies enrolling now · 12 studies all time
What they study most
Anal Cancer, Cervical Cancer, Cognitive/Functional Effects, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ, Endometrial Cancer, Head and Neck Cancer, Lung Cancer, Metastatic Cancer, Mucositis, Neurotoxicity, Osteoporosis
Studies at this site
- Radiation Therapy in Treating Patients With Stage II Prostate Cancer — Completed
- Radiation Therapy in Treating Patients With Stage II Prostate Cancer — Completed
- Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer — Completed
- Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer — Completed
- Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer — Completed
- Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery — Completed
- Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck — Completed
- Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer — Completed
- Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer — Stopped early
- Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy — Completed
- Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors — Completed
- Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer — Completed